UBS Group’s CRH Medical Corporation CRHM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-60,537
| Closed | -$239K | – | 9089 |
|
|
2021
Q1 | $239K | Buy |
60,537
+59,037
| +3,936% | +$233K | ﹤0.01% | 4395 |
|
|
2020
Q4 | $4K | Hold |
1,500
| – | – | ﹤0.01% | 6933 |
|
|
2020
Q3 | $3K | Sell |
1,500
-926
| -38% | -$1.85K | ﹤0.01% | 6720 |
|
|
2020
Q2 | $5K | Buy |
2,426
+926
| +62% | +$1.91K | ﹤0.01% | 6550 |
|
|
2020
Q1 | $2K | Sell |
1,500
-1,720
| -53% | -$2.29K | ﹤0.01% | 6758 |
|
|
2019
Q4 | $11K | Sell |
3,220
-179,851
| -98% | -$614K | ﹤0.01% | 6185 |
|
|
2019
Q3 | $564K | Sell |
183,071
-1,977
| -1% | -$6.09K | ﹤0.01% | 3631 |
|
|
2019
Q2 | $561K | Buy |
185,048
+181,969
| +5,910% | +$552K | ﹤0.01% | 3464 |
|
|
2019
Q1 | $8K | Sell |
3,079
-22,755
| -88% | -$59.1K | ﹤0.01% | 6138 |
|
|
2018
Q4 | $79K | Sell |
25,834
-2,248
| -8% | -$6.87K | ﹤0.01% | 4858 |
|
|
2018
Q3 | $111K | Sell |
28,082
-179,952
| -87% | -$711K | ﹤0.01% | 4650 |
|
|
2018
Q2 | $645K | Buy |
208,034
+3,034
| +1% | +$9.41K | ﹤0.01% | 3375 |
|
|
2018
Q1 | $523K | Buy |
205,000
+180,000
| +720% | +$459K | ﹤0.01% | 3429 |
|
|
2017
Q4 | $66K | Buy |
25,000
+13,000
| +108% | +$34.3K | ﹤0.01% | 4703 |
|
|
2017
Q3 | $31K | Buy |
12,000
+4,947
| +70% | +$12.8K | ﹤0.01% | 5247 |
|
|
2017
Q2 | $41K | Buy |
7,053
+1,083
| +18% | +$6.3K | ﹤0.01% | 4884 |
|
|
2017
Q1 | $49K | Buy |
5,970
+4,824
| +421% | +$39.6K | ﹤0.01% | 4645 |
|
|
2016
Q4 | $6K | Sell |
1,146
-5,167
| -82% | -$27.1K | ﹤0.01% | 6205 |
|
|
2016
Q3 | $24K | Buy |
+6,313
| New | +$24K | ﹤0.01% | 5275 |
|
|
2016
Q2 | – | Sell |
-9,673
| Closed | -$32K | – | 7000 |
|
|
2016
Q1 | $32K | Buy |
9,673
+2,873
| +42% | +$9.5K | ﹤0.01% | 5031 |
|
|
2015
Q4 | $20K | Buy |
6,800
+4,900
| +258% | +$14.4K | ﹤0.01% | 5576 |
|
|
2015
Q3 | $6K | Buy |
+1,900
| New | +$6K | ﹤0.01% | 6214 |
|